Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-03

Clinical Trial Update: Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety of clavulanic acid (CLAV) interaction with cocaine in individuals with cocaine dependence; results completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clavulanic Acid (clavulanic acid)
  • Cocaine (cocaine)

Snippet

Sponsor: Temple University | Conditions: Cocaine Dependence, Cocaine Addiction | Phase 1 | Status: COMPLETED | Results posted: 2023-11-03